SEC Form D private-offering filing

PERSISTA BIO INC.

A new SEC Form D private-offering notice from City Of Lewes, DE, an undisclosed offering target in Biotech. The source filing is one click away.

PERSISTA BIO INC. site↗ Verified via SEC Form D

Biotechnology company developing an implantable cell therapy device that automatically regulates blood sugar to treat type 1 diabetes without daily injections.

Filed 2026-04-29Filed to raise UndisclosedFirst money in 2026-04-14HQ (as filed) City Of Lewes, DESector Biotech Stage (inferred) IndeterminateCall status No reported sale
Source linked the Form D on EDGAR↗Website verified persistabio.com↗Named in the filing 1 executive & director

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.